Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jul 1;111(7):641-643.
doi: 10.1093/jnci/djy203.

Double Trouble: Contralateral Breast Cancer Risk Management in the Modern Era

Kevin J Cheung  1 , Nancy E Davidson  1
Affiliations
Comment

Double Trouble: Contralateral Breast Cancer Risk Management in the Modern Era

Kevin J Cheung et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;34716:1227–1232. - PubMed
    1. Schaapveld M, Visser O, Louwman MJ et al. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol. 2008;268:1239–1246. - PubMed
    1. Aalders KC, van Bommel ACM, van Dalen T et al. Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer. Eur J Cancer. 2016;63:118–126. - PubMed
    1. Gierach GL, Curtis RE, Pfeiffer RM et al. Association of adjuvant tamoxifen and aromatase inhibitor therapy with contralateral breast cancer risk among US women with breast cancer in a general community setting. JAMA Oncol. 2017;32:186–193. - PMC - PubMed
    1. Nichols HB, de González AB, Lacey JV et al. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol. 2011;2912:1564–1569. - PMC - PubMed

Publication types